Grant - Vedanta Biosciences
Investment Firm
Overview
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Announced Date
Dec 05, 2019
Funding Type
Grant
Highlights
Location
United States, North America
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
 CARB-X |
Round Details and Background
Vedanta Biosciences raised $5800000 on 2019-12-05 in Grant
Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.
Company Funding History
17
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Apr 25, 2023 |  Series E - Vedanta Biosciences | 18 | - | 106.5M |
| Feb 22, 2024 | Venture Round - Vedanta Biosciences | 1 | - | undefined |
| Apr 30, 2024 | Grant - Vedanta Biosciences | 1 | - | 3.9M |
| Jun 06, 2016 | Private Equity Round - Vedanta Biosciences | 3 | - | 50.0M |
Recent Activity
There is no recent news or activity for this profile.